Aldeyra Therapeutics Inc. (ALDX)
NASDAQ · Healthcare
Aldeyra Therapeutics Inc. Shareholder Equity 2020–2025
Aldeyra Therapeutics Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Aldeyra Therapeutics Inc. shareholder equity as of December 31, 2025: 44.3M, a 37.68% decrease year-over-year.
- Aldeyra Therapeutics Inc. shareholder equity for 2025 were 44.3M, a 37.68% decrease from 2024.
- Aldeyra Therapeutics Inc. shareholder equity for 2024 were 71.0M, a 40.73% decrease from 2023.
- Aldeyra Therapeutics Inc. shareholder equity for 2023 were 119.8M, a 20.67% decrease from 2022.
- Aldeyra Therapeutics Inc. shareholder equity for 2022 were 151.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aldeyra Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $44 |
| 2024 | $71 |
| 2023 | $120 |
| 2022 | $151 |
| 2021 | $206 |
| 2020 | $60 |
Aldeyra Therapeutics Inc. Shareholder Equity — FAQ
Aldeyra Therapeutics Inc. (ALDX) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALDX's shareholder equity history?
The chart and table above show Aldeyra Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.